Robert R Graham Selected Research

Robert R Graham Research Topics

Disease

17	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2015 - 09/2002
9	Autoimmune Diseases (Autoimmune Disease) 12/2015 - 09/2002
6	Rheumatoid Arthritis 06/2019 - 09/2002
6	Alzheimer Disease (Alzheimer's Disease) 11/2018 - 08/2012
3	Inflammation (Inflammations) 10/2022 - 05/2011
2	Neoplasms (Cancer) 02/2014 - 05/2011
2	IgA Deficiency 01/2012 - 04/2007
2	Disease Susceptibility (Diathesis) 08/2007 - 09/2002
1	Asthma (Bronchial Asthma) 10/2022
1	Cognitive Dysfunction 01/2022
1	Glaucoma 01/2020
1	Schizophrenia (Dementia Praecox) 01/2020
1	Parkinson Disease (Parkinson's Disease) 12/2019
1	Infections 11/2018
1	Geographic Atrophy 01/2017
1	Macular Degeneration (Age-Related Maculopathy) 01/2017
1	Hypersensitivity (Allergy) 11/2016
1	Lupus Nephritis 12/2014
1	Crohn Disease (Crohn's Disease) 02/2014
1	Starvation 02/2014
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2013
1	Primary Immunodeficiency Diseases 01/2012
1	Necrosis 03/2011
1	Arthritis (Polyarthritis) 02/2011
1	Oral Ulcer (Mouth Ulcer) 02/2011
1	HIV Infections (HIV Infection) 12/2010
1	Virus Diseases (Viral Diseases) 12/2010
1	Genetic Predisposition to Disease (Genetic Predisposition) 09/2010
1	Nephritis 01/2008
1	Type 2 Diabetes Mellitus (MODY) 03/2005
1	Type 1 Maturity-Onset Diabetes of the Young 03/2005

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2010
5	HLA Antigens (Human Leukocyte Antigens)IBA 11/2012 - 09/2002
3	InterferonsIBA 01/2014 - 03/2011
3	Interferon Type IIBA 10/2012 - 05/2006
3	AutoantibodiesIBA 03/2011 - 08/2007
2	CytokinesIBA 10/2022 - 03/2011
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 08/2012
2	Biological ProductsIBA 12/2019 - 02/2014
2	Pharmaceutical PreparationsIBA 01/2015 - 02/2014
2	HLA-DR2 Antigen (HLA DR2 Antigen)IBA 12/2014 - 08/2007
2	Immunoglobulin A (IgA)IBA 01/2012 - 09/2010
2	AntibodiesIBA 10/2011 - 01/2008
2	HLA-DRB1 Chains (HLA DRB1)IBA 02/2011 - 09/2002
2	DNA (Deoxyribonucleic Acid)IBA 01/2008 - 04/2007
1	Kallikreins (Kallikrein)IBA 10/2022
1	PeriostinIBA 10/2022
1	Neutralizing AntibodiesIBA 10/2022
1	Biomarkers (Surrogate Marker)IBA 10/2022
1	Peptide Hydrolases (Proteases)FDA Link 10/2022
1	Complement System Proteins (Complement)IBA 01/2020
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 06/2019
1	Immunoglobulins (Immunoglobulin)IBA 11/2018
1	Glycoproteins (Glycoprotein)IBA 11/2018
1	LigandsIBA 11/2018
1	lampalizumabIBA 01/2017
1	salicylhydroxamic acid (SHAM)IBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2017
1	Complement Factor D (Factor D)IBA 01/2017
1	chemotactic factor inactivatorIBA 01/2017
1	Complement Factor I (C3b Inactivator)IBA 01/2017
1	Apolipoproteins E (ApoE)IBA 01/2017
1	Deoxyribonucleases (DNase)FDA Link 11/2016
1	Surface Antigens (Surface Antigen)IBA 12/2015
1	Alanine (L-Alanine)FDA Link 02/2015
1	Threonine (L-Threonine)FDA Link 02/2015
1	Netrin ReceptorsIBA 12/2014
1	Messenger RNA (mRNA)IBA 12/2014
1	HLA-DR3 Antigen (HLA DR3 Antigen)IBA 12/2014
1	Antigen-Antibody Complex (Immune Complex)IBA 12/2014
1	CaspasesIBA 02/2014
1	Caspase 3 (Caspase-3)IBA 02/2014
1	Death Domain ReceptorsIBA 02/2014
1	ChemokinesIBA 01/2014
1	macrophage stimulating proteinIBA 01/2013
1	anti-dsDNA autoantibodyIBA 03/2011
1	Amino Acids FDA Link 12/2010
1	Peptides (Polypeptides)IBA 12/2010
1	Antinuclear AntibodiesIBA 05/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2010
1	Interleukin-10 (Interleukin 10)IBA 11/2009
1	ProlactinIBA 05/2009
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2009
1	P-2 (P 2)IBA 09/2007
1	Histocompatibility Antigens Class IIIBA 08/2007
1	Factor V (Coagulation Factor V)IBA 04/2007
1	Interferon Regulatory FactorsIBA 05/2006
1	Hepatocyte Nuclear FactorsIBA 03/2005
1	EpitopesIBA 09/2002

Therapy/Procedure

1	Intravitreal Injections 01/2017